Soviero Asset Management’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,833
Closed -$135K 38
2023
Q1
$135K Sell
10,833
-4,167
-28% -$55.3K 0.07% 44
2022
Q4
$149K Sell
15,000
-26,667
-64% -$298K 0.09% 28
2022
Q3
$615K Hold
41,667
0.23% 28
2022
Q2
$615K Buy
41,667
+16,667
+67% +$251K 0.23% 28
2022
Q1
$447K Buy
+25,000
New +$473K 0.11% 36

Other funds holding DARE

Soviero Asset Management's DARE Position: Q2 2023 in Review

Soviero Asset Management sold out of Dare Bioscience (DARE) in Q2 2023, closing a stake of 10,833 shares — an estimated $135K sold.

Soviero Asset Management first reported a position in DARE in Q1 2022 and held it in 5 quarters. The position peaked at $615K in Q3 2022. 28 funds tracked by Wall St. Rank hold DARE as of Q2 2023.

  • Soviero Asset Management reported no remaining Dare Bioscience position as of Q2 2023 after selling out during the quarter.
  • Soviero Asset Management sold 10,833 Dare Bioscience shares in Q2 2023, an estimated $135K.
  • Soviero Asset Management first reported a position in Dare Bioscience in Q1 2022 and held it in 5 quarters.
  • Soviero Asset Management's Dare Bioscience position peaked at $615K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2023.

Based on Soviero Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.